6,678 trials
Failed Back Surgery Syndrome · Back Pain · Pain in Leg, Unspecified
Primary: Compare Proportion of Subjects With ≥50% Reduction in Low Back Pain Intensity Between the Treatment Groups — 15; 5 Participants — p=0.036
Total Knee Arthroplasty
Primary: Prothrombin Fragment (PF1.2), a Marker of Thrombin Generation — 263.6; 266.5; 935.8; 615.9 pMol/L
Pain · Anxiety · Nausea
Primary: Subject Perception of Pain and Anxiety During Uterine Aspiration — 74.3; 70.1; 68.2; 60.9 mm
COPD
Primary: Number of Subjects With a Primary Event of Respiratory Death, First COPD-Related Emergency Room Visit, or First COPD Exacerbation-Related Hospitalisation — 64; 57…
Bone Diseases, Metabolic · Osteoporosis, Postmenopausal
Primary: Urinary-N-telopeptide — 47.2; 51.6; 44.5; 47 nml BCE/nmol creatinine
Influenza
Primary: Number of Participants Who Received the Influenza Vaccine — 59; 37; 40 Participants
Arthritis, Rheumatoid
Primary: Number of Participants With Serious Adverse Events (SAEs) and Non-Serious Adverse Events (NSAEs) — 4; 24 participants
Chronic Low Back Pain · Degenerative Disc Disease · Depression
Primary: Percent Change in Average Daily Pain Score — 38.6; 30.0; 20.6 percent change — p=0.01
Metastatic Castration-Resistant Prostate Cancer
Primary: Radiographic Progression-free Survival (rPFS) — 8.1 Months
Lumbar Spinal Stenosis · Thoracic Spinal Stenosis
Primary: Change in Hemoglobin Level From Preoperative Appointment to Postoperative Hospital Discharge — -3.2; -4.6 grams per deciliter (g/dL) — p=0.1318
Tonsillitis · Airway Obstruction · Difficulty Swallowing
Primary: Total Pain Medication — 1.7; 2.2 mg
Thermal Burns
Primary: Narcotic Consumption (Measured in mg/kg Narcotic Consumption) — 57.5; 67.75 mg/kg narcotic consumption
Typical Facial Pain · Atypical Facial Pain
Primary: The Proportion of Subjects Reporting at Least 50% Overall Pain Relief — 19; 14; 10; 16 Participants — p=.196
Parapsoriasis
Primary: Mean Percentage Change From Baseline in the Product of BSA (%) and the sPGA Which is Considered as the Total Psoriasis Severity Index at Week 16 — -10.17; -48.07…
Erythromelalgia
Primary: Carbamazepine Affects Pain in Patients With S241T NaV1.7 IEM Mutation — 3015; 136; 6360; 915 minutes